MentionFox
Home › Executive changes › Lipella Pharmaceuticals Inc.
Leadership changes · LIPO · SEC Form 8-K, Item 5.02

Leadership changes at Lipella Pharmaceuticals Inc. (2026)

Before you join, sell to or invest in Lipella Pharmaceuticals Inc.

MentionFox check on Lipella Pharmaceuticals Inc.: 2 red flags found in 3 sources (checked 14 November 2026). mentionfox.com/c/executive-changes/lipella-pharmaceuticals

  • Bankruptcy filing disclosed Jul 2026 (filing)
  • Bankruptcy filing disclosed Mar 2026 (filing)

Check Lipella Pharmaceuticals Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Lipella Pharmaceuticals Inc.?

Who joined and who left Lipella Pharmaceuticals Inc. (LIPO)? 1 departure reported on 2026-02-04, each cited to the company's own filing.

As of November 14, 2026, Lipella Pharmaceuticals Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 4, 2026, naming 1 departure. The latest filing names Lori A. Birder, leaving (Form 8-K, February 4, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

2 more records on Lipella Pharmaceuticals Inc. ↓

Sell to companies like Lipella Pharmaceuticals Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Out (departing)1
Latest filing2026-02-04

Lipella Pharmaceuticals Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-04. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Lipella Pharmaceuticals Inc. files it.

Also on the record for Lipella Pharmaceuticals Inc.

DateRecordFigureOur pageSource
April 1, 2025Form D, private offering$9K soldForm D pageSource
January 7, 2025Form D, private offering$2.60M soldForm D pageSource

Selling to them or working with them? See who runs Lipella Pharmaceuticals Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Lipella Pharmaceuticals Inc. and the records around it.

Lipella Pharmaceuticals Inc. elsewhere on the record

Want the whole picture on Lipella Pharmaceuticals Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Lipella Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Lipella Pharmaceuticals Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    5 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-04Out8-K, 2026-02-04

Why did they leave? What the filings say

For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.

Selling to Lipella Pharmaceuticals Inc.?

New leaders reset buying decisions — get the Full Report on Lipella Pharmaceuticals Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Lipella Pharmaceuticals Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Lipella Pharmaceuticals Inc., with the record behind each one.

Find candidates like senior executive at Lipella Pharmaceuticals Inc.

Every change, in the filing's words

Filed 2026-02-04 · 8-K

Departing: Lori A. Birder

On February 3, 2026, Lori A. Birder notified Lipella Pharmaceuticals Inc. (the "Company") of her resignation from the Company's Board of Directors, effective immediately.

Tools for this story

Each opens in a new tab, filled in for Lipella Pharmaceuticals Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/lipella-pharmaceuticals
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Lipella Pharmaceuticals Inc. executive departure 2026. MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/lipella-pharmaceuticals